Canadian Food Inspection Agency Canada
Français Contact Us Help Search Canada Site
Home What's New Acts and Regulations Site Map
Food Safety Animal Health Plant Protection Corporate Affairs

bullet BSE in North America
bullet BSE Safeguards
bullet Surveillance and Animal Tracking
bullet BSE Enhanced Surveillance Program
- Results
- News Releases
- Objectives
- Questions and Answers
- Reimbursement Program
- Testing and Sampling

Animals > Animal Diseases > Bovine Spongiform Encephalopathy > Safeguards  

BSE Enhanced Surveillance - Questions and Answers

Q. Why is the Government of Canada enhancing targeted surveillance for BSE in Canada?
A. As unwelcome as is the possibility of detecting another case of BSE, it is important to demonstrate Canada's ability to find additional BSE cases if they exist.
Q. Who benefits from enhancing BSE surveillance in Canada?
A. Canada considers itself to be a minimal risk country for BSE, but this assertion must be backed up by surveillance results. Increasing surveillance will confirm Canada is actively seeking any infected animals and it will demonstrate the prevalence of BSE in Canada. These two goals are critical to keeping domestic consumer confidence high while maintaining or re-establishing international markets.

Producers and processors benefit because domestic and international confidence in our regulatory system and our products is enhanced. Indirectly, Canadian consumers benefit from increased surveillance as it improves our knowledge of the level of prevalence of BSE in Canada.

Q. Will increased testing better protect consumers?
A. Surveillance testing is sometimes confused as a food safety measure. Canada does not test animals to protect human health. Surveillance testing measures the prevalence of the disease and the effectiveness of the measures in place to mitigate the spread of the disease through the cattle population.

The removal of specified risk material (SRM) is the most effective measure to protect people from BSE. SRM are removed at slaughter from all cattle destined for the food supply. SRM removal is based on scientific research that shows that BSE infectivity is localized in certain tissues. The removal of these tissues from the food supply reduces the risk of human exposure to BSE. SRM include the skull, brain, trigeminal ganglia, eyes, tonsils, vertebral column, spinal cord, and dorsal rood ganglia of cattle older than 30 months of age. The small intestine of cattle of all ages is also removed.

Q. Isn't the feed ban in place to protect consumers?
A. The feed ban is one of the measures that indirectly protects consumers. Although the removal of specified risk material (SRM) is the most effective and direct measure, the feed ban prevents the spread of BSE within the cattle population and will, over time, result in the disease being eliminated from the Canadian cattle population.
Q. How many samples does Canada have to test?
A. The CFIA is working in partnership with producers, industry, veterinary practitioners and provinces / territories to increase the intensity of BSE surveillance testing. Targeting a minimum of 8,000 samples in 2004, the national BSE surveillance will continue to ramp up to achieve a minimum of 30,000 samples in subsequent years.
Q. Why is Canada increasing testing now? Do we have BSE because we didn't test enough before?
A. Canada has been testing cattle for the presence of BSE since 1990, at a level consistent with international guidelines and clearly appropriate to a country with no cases of BSE. In the past, the sole purpose of Canada's BSE surveillance was to determine whether the disease was present in the country. With the detection of BSE in an animal born and raised in Canada, the objectives of the surveillance program have changed and the intensity of surveillance testing must be increased to confirm the level of BSE in the country, and to monitor the effectiveness of the control measures that are in place.
Q. Why isn't Canada testing all cows for BSE like some other countries say they do?
A. The purpose of our surveillance program is to establish an estimate of the prevalence of BSE in Canada and to gauge the effectiveness of our risk management measures.

Testing all animals slaughtered for human consumption is not supported by science as an effective food safety measure. The removal of specified risk materials from animals at slaughter is the most effective food safety measure that can be taken.

Testing all animals is not recommended by the OIE, the world organization for animal health and international standards setting body, nor is it recommended by the majority of countries affected by BSE or the international teams of experts that reviewed the Canadian and American BSE responses.

Available tests have not been validated for use in animals under the age of 24 months. Canada is looking for BSE in the animal population most likely to be affected -- animals older than 30 months that are down, diseased, dead or dying. Testing healthy or young animals would not provide an accurate estimate of the prevalence of BSE in Canada nor would it add any level of protection to consumers.

Q. Canada is often described as a minimal risk country for BSE. What does "minimal risk" mean and who decides what countries are minimal risk?
A. Minimal risk is a designation that implies that a country's risk of having a certain level of the disease is very low. The OIE (the World Organization for Animal Health), an internationally recognized body, has established criteria that qualify a country as having "minimal risk" for BSE. Countries that meet the OIE criteria can identify themselves as minimal risk.
Q. Since we already say we're a minimal risk country, why do we need to increase testing?
A. Although there are compelling reasons to conclude that Canada is equivalent to the OIE's definition of a minimal risk country, the only way to validate and confirm this designation is through increased surveillance testing. Domestic and international consumers expect that Canada will increase the intensity of BSE surveillance in order to demonstrate, in a tangible way, that the level of BSE in the country is in fact minimal. Only after an appropriate number of samples have been tested for BSE will domestic consumers and international trading partners fully accept that Canada is a minimal risk country.
Q. What happens if Canada find more cases than the OIE says qualifies countries as minimal risk?
A. Although the true prevalence of BSE in Canada has not been determined, all indications are that Canada qualifies as a minimal risk country as defined by the OIE. In the unlikely event that BSE surveillance confirms a disease prevalence that exceeds the OIE definition of a minimal risk country, although disappointing, it would not alter the soundness of the preventive measures in place.

Exceeding the OIE definition of a minimal risk country would extend the period of Canada's BSE recovery, but the beef supply would remain safe because specified risk materials have been removed, and the health of the national cattle herd would continue to be protected by the feed ban.

Q. What if we fail to meet our surveillance targets?
A. Not testing enough animals would affect Canada's ability to claim that we are a minimal risk country. Many of our trading partners may instead categorize us a higher risk, which would affect our ability to export and force us to reconsider our risk mitigation measures.

In addition, consumer confidence, particularly domestic, may suffer. Canadians and consumers worldwide have invested their trust in the safety of Canada's BSE safeguards. This trust may be lost if our actions to respond to BSE are considered inadequate, especially at the farm level.

Q. How will increased surveillance testing protect the Canadian herd?
A. Increased BSE surveillance will determine the level of disease in Canada, advance the development of appropriate control measures, and monitor their effectiveness -- all of which are necessary steps towards eliminating BSE from the cattle population.
Q. Is it likely we will find more cases of BSE in Canada?
A. Animal disease experts from Canada and other countries have maintained that there may be additional cases in this part of the world. Indeed, given the collective international experience, it's reasonable to expect that increased surveillance will lead to some additional North American cases being found.

The incubation period for BSE is four to six years. Accordingly, it's important to remember that the detection of additional cases would not be a reflection of the effectiveness of measures now in place, but rather of circumstances that took place some time ago.

Q. Won't finding more cases of BSE in Canada close our existing markets or delay opening others?
A. There is broad recognition at the international level that Canada has acted responsively and proactively to limit the spread of BSE. There are, however, no guarantees that the detection of additional cases will not generate negative reactions from some trading partners.
Q. Should consumers reconsider their confidence in Canada’s beef supply?
A. In Canada, BSE continues to pose a very low risk to human health. The regulatory requirement for the removal of all specified risk material (SRM) from carcasses at slaughter instituted in July 2003 was the most effective public health protection measure that could be taken. SRM are tissues that are most likely to contain the BSE agent in infected cattle. This measure is internationally recognized as the most effective means to protect public health from BSE.

The prevalence of BSE in North America is low and the majority of cattle slaughtered in Canade are young cows, considerably less likely to develop infective levels of the disease. All cattle exhibiting symptoms consistent with BSE have been, and continue to be, diverted from the food system. In this regard, it is important to note that every head of cattle destined for food is and has been subject to a pre- and post-mortem examination. In regards to birth cohort risk, international research shows that finding more than one case of BSE in a birth cohort is rare. This has consistently been shown in North America and internationally, even in the United Kingdom during the height of the BSE epidemic.

Q. Can BSE be transmitted through muscle meat or from cow's milk?
A. To date, BSE research continues to demonstrate that beef (meat) and milk from cattle affected with BSE have not been shown to transmit the disease experimentally. Based on these studies, Health Canada continues to agree with the World Health Organization, that with the proper removal of SRM and sourcing from healthy cattle, these products are safe.
Producer Information
Q. What would happen to producers if one of their animals tested positive for BSE ?
A. First, a professional team of CFIA veterinarians and technicians would work with an affected producer in carrying out a thorough investigation. Initially, the farm would be placed under quarantine while an investigation is carried out to determine how the animal may have been infected. While the quarantine is in place, animals would be unable to move onto or off of the farm without prior authorization from the CFIA.
Q. Would an investigation involve a producer's entire herd?
A. Future investigations would target only animals of equivalent risk to the affected animal. This includes the most recent born progeny and animals in the birth herd born within a year of the affected animal.

It may also be possible, with current accurate animal records and identification, to delay the destruction of animals of genetic value to a producer for as long as they remain productive, until they either die or are slaughtered.

Q. Who's responsible for Canada's BSE surveillance program?
A. The CFIA is primarily responsible for the delivery of the enhanced surveillance testing program. These responsibilities include:
  • establishing the objectives and framework of the national surveillance program to meet international expectations for BSE surveillance testing;
  • administering the surveillance program so that it more accurately estimates the prevalence of BSE in Canada and to gauge the effectiveness, over time, of the suite of preventative measures Canada has introduced;
  • facilitating education and awareness to promote compliance with regulations and understanding of the value and benefits of the surveillance program;
  • maintaining the National BSE Reference Laboratory;
  • inspecting and enforcing compliance with the relevant acts and regulations; and
  • reporting the results of the surveillance testing, including the detection of any additional cases, to the Canadian public, international organizations and trading partners.
Q. What are the provinces/territories doing?
A. Provincial governments also contribute to BSE surveillance testing through:
  • collaboration with stakeholders in the procurement of appropriate samples;
  • development or maintenance of sufficient laboratory capacity; and
  • participation in ongoing education and awareness activities in support of national surveillance objectives.
Q. What’s the role of producers?
A. Producers have the most to lose, if confidence in Canada's cattle industry erodes. Producers are in the best place to spot the high-risk animals the CFIA needs to test. It's up to producers to report animals that die on the farm, those that are downers, those that display neurological symptoms and those that are dying.
Q. Do private veterinary practitioners have a role?
A. Local veterinary practitioners have an extremely important role. The role of the veterinary practitioner as a "first responder" is critical to the response to a disease outbreak, both in terms of the impact it has on an individual producer and on the national herd as a whole.

To facilitate the role of veterinary practitioners in the enhanced surveillance testing program, the CFIA is providing them with resource materials that will clarify their role as a primary contact for the reporting of dead, dying, diseased or downer animals and to strengthen their ability to consult with their clients on BSE issues.

Q. Will there be any financial help for producers who submit samples?
A. Yes. As one of a number of measures intended to help Canada meet its enhanced national surveillance targets, the CFIA has launched a program where producers and veterinarians will receive payment when services are provided to the CFIA. Such payment will assist the producers in covering a portion of the veterinary examination fees and carcass disposal costs.
Q. If the CFIA ordered one or more animals destroyed, would the producer be fairly compensated?
A. If an animal is ordered destroyed and sampled, the fair market value would be assessed. The compensation could be up to a total of $2,500 per animal. Consideration could be given to postponing the depopulation and sampling of traceback animals until the end of their productive life, as a potential way to limit the disruption to producers as much as possible.

Once the value of the animal has been assessed and the producer has provided the necessary documentation, compensation payments take approximately four-to-six weeks.

Q. Producers may be concerned about participating in the surveillance program. Why should they want to participate?
A. Diligence and dedication is required of all cattle producers and the animal health community if Canada is to meet its surveillance targets. Failing to successfully test these relatively small numbers of animals could prove disastrous. Our claims about being a minimal risk country will be without scientific backing and our commitment to following science and international standards could be questioned. If Canada's surveillance program is to fulfill the expectations of consumers and trading partners, it requires the co-operation and participation of cattle producers and industry to achieve sufficient samples. The responsibility to strengthen the cattle industry rests on each farm, with industry and within the national animal health community across Canada.



Top of Page
Top of Page
Important Notices